One Lambda, a Thermo Fisher Scientific (NASDAQ:TMO) brand, has announced an exclusive licensing agreement with Transcriptome Sciences Inc. (TSI) for its Molecular Microscope® (MMDx™) system. CLIA-licensed and CAP-accredited Kashi Clinical Laboratories, Inc. has adopted the MMDx™ technology in collaboration with Transcriptome Sciences Inc. and will be offering the service to process biopsy samples in the United States. For more information on the MMDx™ test, visit www.molecular-microscope.com.
The full press release can be read at www.nasdaq.com.
The full press release can be read at www.nasdaq.com.